Agilent Technologies, Inc stock page - price, fundamentals, dividends - iOCharts

A

155.62
+0.84 (0.54%)
Agilent Technologies, Inc (NYSE, USD)
Healthcare >
Diagnostics & Research
Market cap
47.22B
Ent value
51.43B
Price/Sales
8.54
Price/Book
9.82
Div yield
0.50%
Div growth
0.95%
Growth years
10
FCF payout
20.60%
Trailing P/E
58.30
Forward P/E
33.76
PEG
6.24
EPS growth
37.50%
1 year return
47.52%
3 year return
32.30%
5 year return
28.08%
10 year return
20.95%
Last updated: 2021-10-19

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open155.96
Daily high157.46
Daily low155.55
Daily Volume996K
All-time high179.28
1y analyst estimate145.94
Beta1.01
EPS (TTM)2.66
Dividend per share0.78
Ex-div date2 Jul 2021
Next earnings date22 Nov 2021

Downside potential

Loading...
Downside potential data
AS&P500
Current price drop from All-time high-13.20%-0.56%
Highest price drop-93.18%-56.47%
Date of highest drop10 Oct 20029 Mar 2009
Avg drop from high-65.01%-11.45%
Avg time to new high69 days12 days
Max time to new high5215 days1805 days

DIVIDENDS

Dividend yield - 5y

Loading...
Dividend yield data
Dividend per share0.78
Dividend yield0.50%
Payout frequencyQuarterly
Maximum yield1.22%
Average yield0.84%
Minimum yield0.43%
Discount to avg yield-69.41%
Upside potential-40.97%
Yield as % of max yield40.81%

Yield distribution (inverse percentile) - 5y

Loading...
Yield distribution data
Dividend yield0.50%
Current yield distribution96.75%
Yield at 100% (Min)0.43%
Yield at 90%0.59%
Yield at 80%0.72%
Yield at 50% (Median)0.88%
Yield at 20%0.96%
Yield at 10%1.02%
Yield at 0% (Max)1.22%

Dividend per share

Loading...
Dividend per share data
Years of growth10 years
CCC statusDividend Contender
Dividend per share0.78
Payout frequencyQuarterly
Ex-div date2 Jul 2021
EPS (TTM)2.66
EPS (1y forward)4.61
EPS growth (5y)37.50%
EPS growth (5y forward)9.35%

Dividend growth

Loading...
Please create a free account or log in to access this chart
Dividend growth data
AS&P500
DGR MR7.78%7.68%
DGR TTM8.24%-2.66%
DGR 3 years-0.31%5.82%
DGR 5 years0.95%6.23%
DGR 10 years-9.64%
DGR 15 years-6.71%
Time since last change announced336 days
EPS growth (5y)37.50%
EPS growth (5y forward)9.35%

Payout ratio

Loading...
Please create a free account or log in to access this chart
Payout ratio data
EPS coverageFCF coverage
TTM27.78%20.60%
Average--
Forward16.83%-

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E58.30
Price to OCF38.77
Price to FCF43.24
Price to EBITDA38.08
EV to EBITDA41.48

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales8.54
Price to Book9.82
EV to Sales9.30

FINANCIALS

Per share

Loading...
Per share data
Current share count303.44M
EPS (TTM)2.66
FCF per share (TTM)3.58

Income statement

Loading...
Income statement data
Revenue (TTM)5.53B
Gross profit (TTM)2.95B
Operating income (TTM)959.00M
Net income (TTM)810.00M
EPS (TTM)2.66
EPS (1y forward)4.61

Margins

Loading...
Margins data
Gross margin (TTM)53.38%
Operating margin (TTM)17.34%
Profit margin (TTM)14.65%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash1.38B
Net receivables1.07B
Total current assets3.51B
Goodwill5.06B
Intangible assets5.06B
Property, plant and equipment0.00
Total assets10.40B
Accounts payable423.00M
Short/Current long term debt2.73B
Total current liabilities1.76B
Total liabilities5.59B
Shareholder's equity4.81B
Net tangible assets-249.00M

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)1.22B
Capital expenditures (TTM)126.00M
Free cash flow (TTM)1.09B
Dividends paid (TTM)225.00M

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity16.86%
Return on Assets8.37%
Return on Invested Capital11.09%
Cash Return on Invested Capital14.95%
COMPANY DETAILS
A (Agilent Technologies, Inc) company logo
Marketcap
47.22B
Marketcap category
Large-cap
Description
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; inductively coupled plasma mass and optical emission spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate readers; laboratory software, information management, and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment to produce synthesized oligonucleotide. It also offers immunohistochemistry, in situ hybridization, and hematoxylin and eosin staining and special staining; instruments, consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. It has collaboration agreement with SGS AXYS. The company was incorporated in 1999 and is headquartered in Santa Clara, California.
Employees
16500
SEC filings
CEO
Michael McMullen
Country
USA
City
Santa Clara
Stock type
Common stock
CCC status
Dividend Contender
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
October 19, 2021
In this article, we will take a look at the 11 best genomic stocks to buy now. If you want to skip our detailed analysis of these stocks, go directly to 5 Best Genomic Stocks to Buy Now. Genomics is a...
October 17, 2021
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
October 14, 2021
Smart Beta ETF report for FTCS
October 13, 2021
SANTA CLARA, Calif., October 13, 2021--Agilent Technologies Inc. (NYSE: A) today announced its Ki-67 IHC MIB-1 pharmDx (Dako Omnis) is now FDA approved as an aid in identifying patients with early bre...
October 12, 2021
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge funds and institutional investors spend millions o...
October 7, 2021
Proposed tax increases on domestic and foreign profits would drive rates up for Agilent and Advance Auto, but in different ways.
October 5, 2021
Investors are optimistic about Illumina (ILMN) owing to its strategic partnerships and wider market adoption of its products.
September 30, 2021
This Buffett acolyte is beating Berkshire at its own game.
September 28, 2021
SANTA CLARA, Calif., September 28, 2021--Agilent Technologies Inc. (NYSE: A) today announced Professor Bernhard Lendl has been selected to receive a prestigious Agilent Thought Leader Award. Highly re...
September 23, 2021
SANTA CLARA, Calif., September 23, 2021--Pfizer executive Dr. Mikael Dolsten appointed to Agilent board of directors.
Next page